Market Research Logo

ArQule, Inc. - Product Pipeline Review - 2015

ArQule, Inc. - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘ArQule, Inc. - Product Pipeline Review - 2015’, provides an overview of the ArQule, Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of ArQule, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of ArQule, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of ArQule, Inc.’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the ArQule, Inc.’s pipeline products
Reasons to buy
  • Evaluate ArQule, Inc.’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of ArQule, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the ArQule, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of ArQule, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of ArQule, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of ArQule, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues


ArQule, Inc. Snapshot
ArQule, Inc. Overview
Key Information
Key Facts
ArQule, Inc. - Research and Development Overview
Key Therapeutic Areas
ArQule, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
ArQule, Inc. - Pipeline Products Glance
ArQule, Inc. - Late Stage Pipeline Products
Phase III Products/Combination Treatment Modalities
ArQule, Inc. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
ArQule, Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
ArQule, Inc. - Drug Profiles
tivantinib
Product Description
Mechanism of Action
R&D Progress
ARQ-087
Product Description
Mechanism of Action
R&D Progress
ARQ-092
Product Description
Mechanism of Action
R&D Progress
ARQ-761
Product Description
Mechanism of Action
R&D Progress
ARQ-751
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit BTK for Cancer
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit S6K for Cancer
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit Kinase for Oncology
Product Description
Mechanism of Action
R&D Progress
ArQule, Inc. - Pipeline Analysis
ArQule, Inc. - Pipeline Products by Target
ArQule, Inc. - Pipeline Products by Route of Administration
ArQule, Inc. - Pipeline Products by Molecule Type
ArQule, Inc. - Pipeline Products by Mechanism of Action
ArQule, Inc. - Recent Pipeline Updates
ArQule, Inc. - Dormant Projects
ArQule, Inc. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
ARQ-171
tivantinib
ArQule, Inc. - Company Statement
ArQule, Inc. - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
ArQule, Inc., Key Information
ArQule, Inc., Key Facts
ArQule, Inc. - Pipeline by Indication, 2015
ArQule, Inc. - Pipeline by Stage of Development, 2015
ArQule, Inc. - Monotherapy Products in Pipeline, 2015
ArQule, Inc. - Phase III, 2015
ArQule, Inc. - Phase II, 2015
ArQule, Inc. - Phase I, 2015
ArQule, Inc. - Preclinical, 2015
ArQule, Inc. - Discovery, 2015
ArQule, Inc. - Pipeline by Target, 2015
ArQule, Inc. - Pipeline by Route of Administration, 2015
ArQule, Inc. - Pipeline by Molecule Type, 2015
ArQule, Inc. - Pipeline Products by Mechanism of Action, 2015
ArQule, Inc. - Recent Pipeline Updates, 2015
ArQule, Inc. - Dormant Developmental Projects,2015
ArQule, Inc. - Discontinued Pipeline Products, 2015
List of Figures
ArQule, Inc. - Pipeline by Top 10 Indication, 2015
ArQule, Inc. - Pipeline by Stage of Development, 2015
ArQule, Inc. - Monotherapy Products in Pipeline, 2015
ArQule, Inc. - Pipeline by Top 10 Target, 2015
ArQule, Inc. - Pipeline by Top 10 Route of Administration, 2015
ArQule, Inc. - Pipeline by Top 10 Molecule Type, 2015
ArQule, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report